BE869485A - Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent - Google Patents

Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent

Info

Publication number
BE869485A
BE869485A BE189673A BE189673A BE869485A BE 869485 A BE869485 A BE 869485A BE 189673 A BE189673 A BE 189673A BE 189673 A BE189673 A BE 189673A BE 869485 A BE869485 A BE 869485A
Authority
BE
Belgium
Prior art keywords
doxorubicin
preparation
compositions containing
new derivatives
derivatives
Prior art date
Application number
BE189673A
Other languages
English (en)
Original Assignee
Inst Internat De Pathologie Ce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Internat De Pathologie Ce filed Critical Inst Internat De Pathologie Ce
Priority to BE189673A priority Critical patent/BE869485A/fr
Publication of BE869485A publication Critical patent/BE869485A/fr
Priority to DE2930637A priority patent/DE2930637C2/de
Priority to SE7906464A priority patent/SE446537B/sv
Priority to CH704279A priority patent/CH641960A5/fr
Priority to IT49944/79A priority patent/IT1117790B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
BE189673A 1978-08-03 1978-08-03 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent BE869485A (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BE189673A BE869485A (fr) 1978-08-03 1978-08-03 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent
DE2930637A DE2930637C2 (de) 1978-08-03 1979-07-27 N-(L-Leucyl)-doxorubicin, Verfahren zu dessen Herstellung und dieses enthaltende pharmazeutische Zubereitungen
SE7906464A SE446537B (sv) 1978-08-03 1979-07-30 Doxorubicinderivat, sett att framstella dem samt farmaceutisk komposition innehallande sadant derivat
CH704279A CH641960A5 (en) 1978-08-03 1979-07-31 Doxorubicin derivatives, their preparation and compositions containing them
IT49944/79A IT1117790B (it) 1978-08-03 1979-08-02 Derivati di dossorubicina dotati di attivita'antitumorale procedimento per la loro preparazione e composizioni che li contengono

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE189673A BE869485A (fr) 1978-08-03 1978-08-03 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent
BE869485 1978-08-03

Publications (1)

Publication Number Publication Date
BE869485A true BE869485A (fr) 1978-12-01

Family

ID=25650923

Family Applications (1)

Application Number Title Priority Date Filing Date
BE189673A BE869485A (fr) 1978-08-03 1978-08-03 Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent

Country Status (1)

Country Link
BE (1) BE869485A (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294294A3 (en) * 1987-06-05 1990-05-30 Cytogen Corporation Amine derivatives of anthracycline antibiotics and antibody conjugates thereof
FR2678274A1 (fr) * 1991-06-25 1992-12-31 Medgenix Group Sa N-leucyl epirubicine application a titre de medicament antitumoral et procede de preparation.
WO1996005863A1 (fr) * 1994-08-19 1996-02-29 La Region Wallonne Composes, composition pharmaceutique et dispositif de diagnostic les comprenant et leur utilisation
BE1008581A3 (fr) * 1994-08-19 1996-06-04 Wallone Region Prodrogues, composition pharmaceutique les comprenant et leur utilisation.
US7115573B2 (en) 2000-06-14 2006-10-03 Medarex, Inc. Prodrug compounds with an isoleucine
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0294294A3 (en) * 1987-06-05 1990-05-30 Cytogen Corporation Amine derivatives of anthracycline antibiotics and antibody conjugates thereof
FR2678274A1 (fr) * 1991-06-25 1992-12-31 Medgenix Group Sa N-leucyl epirubicine application a titre de medicament antitumoral et procede de preparation.
US7037898B2 (en) 1994-08-19 2006-05-02 Laregion Wallone Tumor-activated prodrug compounds and treatment
BE1008581A3 (fr) * 1994-08-19 1996-06-04 Wallone Region Prodrogues, composition pharmaceutique les comprenant et leur utilisation.
US5962216A (en) * 1994-08-19 1999-10-05 La Region Wallonne Tumor-activated prodrug compounds and treatment
US6342480B1 (en) 1994-08-19 2002-01-29 La Region Wallone Tumor-activated prodrug compounds and treatment
WO1996005863A1 (fr) * 1994-08-19 1996-02-29 La Region Wallonne Composes, composition pharmaceutique et dispositif de diagnostic les comprenant et leur utilisation
US7390629B2 (en) 1994-08-19 2008-06-24 La Region Wallonne Tumor-activated prodrug compounds and treatment
US7951772B2 (en) 1994-08-19 2011-05-31 La Region Wallonne Tumor-activated prodrug compounds and treatment
US7425541B2 (en) 1998-12-11 2008-09-16 Medarex, Inc. Enzyme-cleavable prodrug compounds
US8034787B2 (en) 1998-12-11 2011-10-11 Medarex, Inc. Enzyme-cleavable prodrug compounds
US7115573B2 (en) 2000-06-14 2006-10-03 Medarex, Inc. Prodrug compounds with an isoleucine
US7329507B2 (en) 2000-06-14 2008-02-12 Medarex, Inc. Prodrug compounds with isoleucine
US7696313B2 (en) 2000-06-14 2010-04-13 Medarex, Inc. Prodrug compounds with isoleucine

Similar Documents

Publication Publication Date Title
PT66175A (fr) Nouveaux derives du dithiole-1,2,leur preparation et les compositions qui les contiennent
BE838194A (fr) Nouveaux derives de l'oxadiazolinone, leur preparation et les compositions qui les contiennent
BE869261A (fr) Nouveaux derives de la pepstatine, leur preparation et les compositions qui les contiennent
BE868888A (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions qui les contiennent
LU78895A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions qui les contiennent
BE869485A (fr) Nouveaux derives de la doxorubicine, leur preparation et les compositions qui les contiennent
LU81182A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions pharmaceutiques qui les contiennent
FR2532310B1 (fr) Nouveaux derives de la benzamide, leur preparation et les compositions pharmaceutiques qui les contiennent
BE877555A (fr) Nouveaux derives de la daunorubicine, leur preparation et les compositions pharmaceutiques qui les contiennent
BE863083A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et les compositions qui les contiennent
BE867129A (fr) Nouveaux derives de l'hydroxy-4 thiazolidinethione-2, leur preparation et les compositions qui les contiennent
FR2351656A1 (fr) Nouveaux derives de la dibenzo(de, h) quinoleine, leur preparation et les compositions qui les contiennent
LU80497A1 (fr) Nouveaux derives de l'isoquinoleine,leur preparation et les compositions qui les contiennent
FR2315277A1 (fr) Nouveaux derives pentacycliques, leur preparation et les compositions qui les contiennent
PT65574A (fr) Nouveaux derives de l'oxadiazine-1,2,4 one-5,leur preparation et les compositions les contenant
FR2314726A1 (fr) Nouveaux derives du naphtagene, leur preparation et les compositions qui les contiennent
FR2290208A1 (fr) Nouveaux derives de l'oxathiinno(1,4)(2,3-c)pyrrole, leur preparation et les compositions qui les contiennent
LU80389A1 (fr) Nouveaux derives de la thiazoline,leur preparation et les compositions qui les contiennent
BE839401A (fr) Nouveaux derives phosphores, leur preparation et les compositions qui les contiennent
BE855710A (fr) Nouveaux derives de la nitro-10 oxo-7h-indolizino (7,6,5-de) isoquinoleine, leur preparation et les compositions qui les contiennent
FR2324305A2 (fr) Nouveaux derives de l'isoindoline, leur preparation et les compositions qui les contiennent
BE840428A (fr) Nouveaux composes heterocycliques, leur preparation et les compositions qui les contiennent
BE875797A (fr) NOUVEAUX DERIVES DE L'ISOQUINOLEINE, LEUR PREPARATION ET LES COMPOSITIONS àPHARMACEUTIQUES QUI LES CONTIENNENT
LU79663A1 (fr) Nouveaux derives de l'hydroxy-4 thiazolidinethione-2,leur preparation et les compositions qui les contiennent
BE883191A (fr) Nouveaux derives de l'isoquinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: INSTITUT INTERNATIONAL DE PATHOLOGIE CELLULAIRE E

Effective date: 19950831